Skylight Health Group Inc.
SLHGF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $27 | $1 | $13 | $0 |
| % Growth | 3,841.5% | -94.9% | – | – |
| Cost of Goods Sold | $12 | $0 | $4 | $0 |
| Gross Profit | $15 | $0 | $9 | $0 |
| % Margin | 55.6% | 39.2% | 69.5% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $29 | $9 | $12 | $0 |
| SG&A Expenses | $31 | $9 | $13 | $0 |
| Sales & Mktg Exp. | $2 | $0 | $1 | $0 |
| Other Operating Expenses | $6 | $1 | $6 | $0 |
| Operating Expenses | $37 | $10 | $19 | $0 |
| Operating Income | -$22 | -$10 | -$9 | -$0 |
| % Margin | -80.5% | -1,426.6% | -69.2% | – |
| Other Income/Exp. Net | -$0 | -$2 | -$2 | -$4 |
| Pre-Tax Income | -$22 | -$12 | -$11 | -$4 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$14 | -$9 | -$11 | -$0 |
| % Margin | -50.6% | -1,376.1% | -81.8% | – |
| EPS | -0.37 | -0.55 | -0.71 | -0.016 |
| % Growth | 32.7% | 22.5% | -4,451.3% | – |
| EPS Diluted | -0.46 | -0.55 | -0.71 | -0.016 |
| Weighted Avg Shares Out | 37 | 22 | 15 | 14 |
| Weighted Avg Shares Out Dil | 37 | 22 | 15 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $1 | $2 | $0 |
| EBITDA | -$16 | -$11 | -$8 | -$2 |
| % Margin | -59.7% | -1,589.1% | -62.5% | – |